Glenmede Trust’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$472K Sell
7,172
-994
-12% -$51.9K ﹤0.01% 986
2025
Q4
$345K Buy
+8,166
New +$333K ﹤0.01% 1082
2025
Q1
$641K Buy
11,285
+3,617
+47% +$226K ﹤0.01% 822
2024
Q4
$531K Sell
7,668
-2,628
-26% -$253K ﹤0.01% 920
2024
Q3
$1.4M Buy
10,296
+359
+4% +$47.2K 0.01% 639
2024
Q2
$1.34M Buy
9,937
+1
+0% +$153 0.01% 633
2024
Q1
$1.71M Sell
9,936
-116
-1% -$17.7K 0.01% 602
2023
Q4
$1.56M Buy
10,052
+104
+1% +$13.6K 0.01% 601
2023
Q3
$1.25M Buy
9,948
+1,359
+16% +$167K 0.01% 615
2023
Q2
$935K Hold
8,589
0.01% 676
2023
Q1
$935K Buy
8,589
+589
+7% +$68K 0.01% 678
2022
Q4
$818K Buy
8,000
+175
+2% +$17.4K ﹤0.01% 708
2022
Q3
$706K Buy
7,825
+29
+0.4% +$3.19K ﹤0.01% 735
2022
Q2
$916K Sell
7,796
-678
-8% -$97.3K 0.01% 702
2022
Q1
$1.21M Sell
8,474
-179
-2% -$27.3K 0.01% 667
2021
Q4
$1.45M Buy
8,653
+138
+2% +$22.5K 0.01% 639
2021
Q3
$1.28M Buy
8,515
+4,347
+104% +$670K 0.01% 635
2021
Q2
$631K Buy
4,168
+96
+2% +$15.2K ﹤0.01% 813
2021
Q1
$610K Buy
4,072
+120
+3% +$16.5K ﹤0.01% 792
2020
Q4
$513K Buy
3,952
+68
+2% +$8.46K ﹤0.01% 838
2020
Q3
$417K Sell
3,884
-464
-11% -$46.3K ﹤0.01% 835
2020
Q2
$375K Sell
4,348
-15,535
-78% -$1.29M ﹤0.01% 838
2020
Q1
$2.45M Hold
19,883
0.01% 583
2019
Q4
$2.45M Sell
19,883
-878,184
-98% -$108M 0.01% 583
2019
Q3
$110K Sell
898,067
-214,428
-19% -$24.2M 0.5% 46
2019
Q2
$120K Buy
1,112,495
+559,791
+101% +$58M 0.53% 43
2019
Q1
$54.5K Sell
552,704
-14,391
-3% -$1.42M 0.25% 112
2018
Q4
$51K Buy
567,095
+388,745
+218% +$38.1M 0.25% 113
2018
Q3
$20.3M Sell
178,350
-69,162
-28% -$7.93M 0.08% 321
2018
Q2
$27.5M Buy
247,512
+26,802
+12% +$2.96M 0.12% 247
2018
Q1
$23.6M Hold
220,710
0.1% 279
2017
Q4
$23.6M Sell
220,710
-41,185
-16% -$4.38M 0.1% 279
2017
Q3
$27.3M Sell
261,895
-50,752
-16% -$4.99M 0.12% 254
2017
Q2
$28.1M Hold
312,647
0.13% 237
2017
Q1
$28.1M Buy
312,647
+24,317
+8% +$2.12M 0.13% 237
2016
Q4
$22.7M Buy
288,330
+272,531
+1,725% +$20.5M 0.12% 269
2016
Q3
$1.05M Buy
15,799
+192
+1% +$12.6K 0.01% 736
2016
Q2
$1.02M Buy
15,607
+978
+7% +$68K 0.01% 742
2016
Q1
$958K Sell
14,629
-583
-4% -$36.2K 0.01% 753
2015
Q4
$1.02M Buy
15,212
+14,806
+3,647% +$1.01M 0.01% 752
2015
Q3
$23K Hold
406
﹤0.01% 1846
2015
Q2
$28K Sell
406
-471
-54% -$31.4K ﹤0.01% 1798
2015
Q1
$47K Sell
877
-51,320
-98% -$2.9M ﹤0.01% 1705
2014
Q4
$3.13M Sell
52,197
-45,631
-47% -$2.67M 0.02% 483
2014
Q3
$5.72M Buy
97,828
+3,452
+4% +$213K 0.05% 393
2014
Q2
$6.06M Buy
94,376
+871
+0.9% +$52.8K 0.05% 390
2014
Q1
$5.19M Buy
93,505
+20,268
+28% +$1.08M 0.05% 402
2013
Q4
$4.05M Buy
73,237
+141
+0.2% +$7.82K 0.04% 423
2013
Q3
$3.86M Sell
73,096
-33,682
-32% -$1.65M 0.05% 408
2013
Q2
$4.78M Buy
+106,778
New +$5.02M 0.06% 337

Other funds holding CE

Glenmede Trust's CE Position: Q1 2026 in Review

Glenmede Trust reduced its Celanese (CE) stake by 12% in Q1 2026, selling an estimated $51.9K and leaving 7,172 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Glenmede Trust first reported a position in CE in Q2 2013 and has held it in 50 quarters since. The position peaked at $28.1M in Q2 2017. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • Glenmede Trust held 7,172 shares of Celanese worth $472K as of Q1 2026.
  • Glenmede Trust sold 994 Celanese shares in Q1 2026, an estimated $51.9K.
  • Celanese made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #986 holding.
  • Glenmede Trust first reported a position in Celanese in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Celanese position peaked at $28.1M in Q2 2017.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.